glp-1-directed nmda receptor antagonism for obesity treatment GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys Targeting GLP-1, GIP & GCG
Pay in 4 interest-free payments of $6.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


























